Search Results 2131-2140 of 21688 for platelets

1. Continued Access To PREVAIL (CAP2) - Mayo Clinic

   The subject has thrombocytopenia (defined as < 70,000 platelets/mm3) or anemia with hemoglobin concentration of < 10 g/dl (i.e., anemia as determined by the ...

2. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

   Platelet count ≥5,000/μL;; Total bilirubin ≤.5 x the upper limit of normal (ULN);; Aspartate transaminase and alanine transaminase ≤ x ULN (≤x ULN in the ...

3. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

   Platelets >= 50,000/mm^3. Hemoglobin >= 8 g/dL. Total bilirubin =< 1.5 x upper limit of normal (ULN) or 3 x ULN for Gilbert's disease. Aspartate ...

4. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

   Platelets ≥100 x 109/L. Life expectancy estimated at ≥3 months. Exclusion Criteria: Anti-cancer chemotherapy, radiotherapy, immunotherapy, or ...

5. Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma - Mayo Clinic

   Platelets >= 100,000 cells/mm^3; Hemoglobin >= 10.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is ...

6. Nedosiran in Pediatric Patients from Birth to 5 Years of Age with PH and Relatively Intact Renal Function - Mayo Clinic

   Severe thrombocytopenia (platelet count ≤ 100,000/µL) 2. Hepatotoxicity, defined as ALT or AST > 3 times the upper ULN and total bilirubin > 2 × ULN or INR ...

7. Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer - Mayo Clinic

   Platelets >= 100,000/mcL; Total bilirubin within normal institutional limits; Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/ ...

8. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   Platelet count ≥ 100,000/mm^3; Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN); Serum glutamic oxaloacetic transaminase (SGOT) ...

9. Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery - Mayo Clinic

   - Platelets > 100,000/mcL. - Total bilirubin < 1.5 x institutional upper limit of normal (ULN). - Aspartate aminotransferase (AST) (serum glutamic ...

10. Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors - Mayo Clinic

    WBC ≥ 3000/UL and Platelet count ≥ 100,000/UL; Serum creatinine ≤ 1.5 mg/dL; Estimated GFR (by Cockcroft-Gault) ≥ 50mL/min; 12 or 24 hour urine creatinine ...